¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"abnormality of cell interaction"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
infant-mother interaction
¿µ¾Æ¾ö¸¶»óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë
orbit interaction
±Ëµµ»óÈ£ÀÛ¿ë
primary interaction
ÀÏÂ÷»óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü¸®°£µå»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼±»óÈ£ÀÛ¿ë
simple interaction
´Ü¼ø»óÈ£ÀÛ¿ë
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
ethmoidal cell
¹úÁý»À¹úÁý
eukaryotic cell
ÁøÇÙ¼¼Æ÷
goblet cell
¼úÀܼ¼Æ÷
hair cell
Åм¼Æ÷
inflammatory cell
¿°Áõ¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Kupffer's cell
º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
genetic interaction
À¯Àü»óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë
infant-mother interaction
¿µ¾Æ¾ö¸¶»óÈ£ÀÛ¿ë
orbit interaction
±Ëµµ»óÈ£ÀÛ¿ë
primary interaction
ÀÏÂ÷»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼±»óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü¹èÀ§ÀÚ»óÈ£ÀÛ¿ë
simple interaction
´Ü¼ø»óÈ£ÀÛ¿ë
tissue interaction
Á¶Á÷»óÈ£ÀÛ¿ë
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
genetic interaction
À¯ÀüÀû »óÈ£ÀÛ¿ë
heme heme interaction
Èû-Èû »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
heme heme interaction
Çð-Çð »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
infant-mother interaction
¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
interaction
»óÈ£ÀÛ¿ë
interaction, primary
ÀÏÂ÷»óÈ£ÀÛ¿ë
photon interaction
±¤ÀÚ»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼± »óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
growth abnormality
¹ßÀ°ÀÌ»ó.
growth abnormality
¼ºÀåÀÌ»ó
metabolic abnormality
´ë»çÀÌ»ó.
oxygen affinity abnormality
»ê¼Òģȼº( öÑûúàõ) ÀÌ»ó
positional abnormality
À§Ä¡ÀÌ»ó(êÈöÇì¶ßÈ).
proton flow abnormality
¾çÀÚ À¯µ¿ ÀÌ»ó
additive interaction
»ó°¡(ßÓÊ¥)ÀÛ¿ë.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
binocular interaction
¾ç¾È»óÈ£ÀÛ¿ë
cellular interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
dipolar interaction
½Ö±ØÀÚ»óÈ£ÀÛ¿ë
dipole dipole interaction
½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½